{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:37:20Z","timestamp":1785325040396,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ejphar.2022.175169","type":"journal-article","created":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T02:14:30Z","timestamp":1659233670000},"page":"175169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Mast cells promote viral entry of SARS-CoV-2 via formation of chymase\/spike protein complex"],"prefix":"10.1016","volume":"930","author":[{"given":"Shuang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Takemasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Mogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2022.175169_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/thx.2008.101683","article-title":"Novel site-specific mast cell subpopulations in the human lung","volume":"64","author":"Andersson","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.ejphar.2022.175169_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0167-4838(00)00076-5","article-title":"Angiotensin II generation by mast cell alpha- and beta-chymases","volume":"1480","author":"Caughey","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2022.175169_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.ejphar.2022.175169_bib4","first-page":"1629","article-title":"Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents. Copyright 2020 Biolife Sas"},{"key":"10.1016\/j.ejphar.2022.175169_bib5","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jaci.2018.10.054","article-title":"Mast cells as protectors of health","volume":"144","author":"Dudeck","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2022.175169_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004100","article-title":"Mast cells expedite control of pulmonary murine cytomegalovirus infection by enhancing the recruitment of protective CD8 T cells to the lungs","volume":"10","author":"Ebert","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejphar.2022.175169_bib7","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2022.175169_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(24)35133-X","article-title":"Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells","volume":"291","author":"He","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2022.175169_bib9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2022.175169_bib10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/1073858420941476","article-title":"COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation","volume":"26","author":"Kempuraj","year":"2020","journal-title":"Neuroscientist"},{"key":"10.1016\/j.ejphar.2022.175169_bib11","first-page":"9","article-title":"Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy","author":"Kritas","year":"2020","journal-title":"J Biol Regul Homeost Agents. Copyright 2019 Biolife Sas"},{"key":"10.1016\/j.ejphar.2022.175169_bib12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ejphar.2022.175169_bib13","article-title":"CRACM3 regulates the stability of non-excitable exocytotic vesicle fusion pores in a Ca(2+)-independent manner via molecular interaction with syntaxin4","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2022.175169_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bcp.2018.02.013","article-title":"Zoledronate modulates intracellular vesicle trafficking in mast cells via disturbing the interaction of myosinVa\/Rab3a and sytaxin4\/VAMP7","volume":"151","author":"Liu","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175169_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00617-17","article-title":"Transcriptional profiling confirms the therapeutic effects of mast cell stabilization in a dengue disease model","volume":"91","author":"Morrison","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2022.175169_bib16","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2022.175169_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00430-015-0386-1","article-title":"Mast cells: innate attractors recruiting protective CD8 T cells to sites of cytomegalovirus infection","volume":"204","author":"Podlech","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.ejphar.2022.175169_bib18","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.4049\/jimmunol.160.10.5136","article-title":"Quercetin sensitizes RBL-2H3 cells to polybasic mast cell secretagogues through increased expression of Gi GTP-binding proteins linked to a phospholipase C signaling pathway","volume":"160","author":"Senyshyn","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2022.175169_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.745515","article-title":"Basic predictive risk factors for cytokine storms in COVID-19 patients","volume":"12","author":"Shcherbak","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2022.175169_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jat.3738","article-title":"Searching for tryptase in the RBL-2H3 mast cell model: preparation for comparative mast cell toxicology studies with zebrafish","volume":"39","author":"Shim","year":"2019","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.ejphar.2022.175169_bib21","series-title":"Signatures of Mast Cell Activation Are Associated with Severe COVID-19. medRxiv","author":"Tan","year":"2021"},{"key":"10.1016\/j.ejphar.2022.175169_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.anai.2020.11.003","article-title":"Potential association of mast cells with coronavirus disease 2019","volume":"126","author":"Theoharides","year":"2021","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ejphar.2022.175169_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbadis.2010.12.014","article-title":"Mast cells and inflammation","volume":"1822","author":"Theoharides","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2022.175169_bib24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijid.2022.02.049","article-title":"Successful treatment of a severe COVID-19 patient using an integrated approach addressing mast cells and their mediators","volume":"118","author":"Theoharides","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejphar.2022.175169_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/abbi.1997.0182","article-title":"Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase","volume":"344","author":"Ware","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2022.175169_bib26","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein","volume":"17","author":"Xia","year":"2020","journal-title":"Cell. Mol. Immunol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922004307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922004307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:04:54Z","timestamp":1757977494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922004307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":26,"alternative-id":["S0014299922004307"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175169","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mast cells promote viral entry of SARS-CoV-2 via formation of chymase\/spike protein complex","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175169"}}